These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26070802)

  • 41. Charcot-Marie-Tooth disease type 1A: a family study with microsatellites.
    Qu Y; Carpenter NJ; Whetsell L; Smith SP; Say B
    J Okla State Med Assoc; 1996 Nov; 89(11):395-9. PubMed ID: 8972170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of comorbidities on the phenotype of patients affected by Charcot-Marie-Tooth neuropathy type 1A.
    Ursino G; Alberti MA; Grandis M; Reni L; Pareyson D; Bellone E; Gemelli C; Sabatelli M; Pisciotta C; Luigetti M; Santoro L; Massollo L; Schenone A
    Neuromuscul Disord; 2013 Nov; 23(11):902-6. PubMed ID: 23891256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
    Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
    Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Whither hope for pharmacological treatment of Charcot-Marie-Tooth disease type 1A?
    Patel PI; Pleasure D
    JAMA Neurol; 2013 Aug; 70(8):969-71. PubMed ID: 23797977
    [No Abstract]   [Full Text] [Related]  

  • 46. [Metabolic therapy for early treatment of age-related macular degeneration].
    Fehér J; Kovács B; Kovács I; Schvöller M; Corrado Balacco G
    Orv Hetil; 2007 Dec; 148(48):2259-68. PubMed ID: 18039616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.
    Patrick DL; Burns T; Morosini P; Gagnon DD; Rothman M; Adriaenssen I
    Clin Ther; 2010 Feb; 32(2):275-92. PubMed ID: 20206786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric Charcot-Marie-Tooth disease type 1A.
    Burns J; Scheinberg A; Ryan MM; Rose KJ; Ouvrier RA
    Muscle Nerve; 2010 Aug; 42(2):262-7. PubMed ID: 20544937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
    Yoshikawa H; Nishimura T; Yanagihara T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pain assessment in Charcot-Marie-Tooth (CMT) disease.
    Ribiere C; Bernardin M; Sacconi S; Delmont E; Fournier-Mehouas M; Rauscent H; Benchortane M; Staccini P; Lantéri-Minet M; Desnuelle C
    Ann Phys Rehabil Med; 2012 Apr; 55(3):160-73. PubMed ID: 22475878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia.
    Bradley WG; Badger GJ; Tandan R; Fillyaw MJ; Young J; Fries TJ; Krusinski PB; Witarsa M; Boerman J; Blair CJ
    Neurology; 1988 Nov; 38(11):1731-9. PubMed ID: 2847079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A LRSAM1 mutation links Charcot-Marie-Tooth type 2 to Parkinson's disease.
    Aerts MB; Weterman MA; Quadri M; Schelhaas HJ; Bloem BR; Esselink RA; Baas F; Bonifati V; van de Warrenburg BP
    Ann Clin Transl Neurol; 2016 Feb; 3(2):146-9. PubMed ID: 26900582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe scurvy: an underestimated disease.
    Levavasseur M; Becquart C; Pape E; Pigeyre M; Rousseaux J; Staumont-Sallé D; Delaporte E
    Eur J Clin Nutr; 2015 Sep; 69(9):1076-7. PubMed ID: 26081492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combining vitamin C and carotenoid biomarkers better predicts fruit and vegetable intake than individual biomarkers in dietary intervention studies.
    McGrath AJ; Hamill LL; Cardwell CR; Draffin CR; Neville CE; Appleton KM; McEneny J; McKinley MC; Young IS; Woodside JV
    Eur J Nutr; 2016 Jun; 55(4):1377-88. PubMed ID: 26081648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vitamin concentrations 5 years after gastric bypass.
    Aaseth E; Fagerland MW; Aas AM; Hewitt S; Risstad H; Kristinsson J; Bøhmer T; Mala T; Aasheim ET
    Eur J Clin Nutr; 2015 Nov; 69(11):1249-55. PubMed ID: 26081488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A.
    Attarian S; Vallat JM; Magy L; Funalot B; Gonnaud PM; Lacour A; Péréon Y; Dubourg O; Pouget J; Micallef J; Franques J; Lefebvre MN; Ghorab K; Al-Moussawi M; Tiffreau V; Preudhomme M; Magot A; Leclair-Visonneau L; Stojkovic T; Bossi L; Lehert P; Gilbert W; Bertrand V; Mandel J; Milet A; Hajj R; Boudiaf L; Scart-Grès C; Nabirotchkin S; Guedj M; Chumakov I; Cohen D
    Orphanet J Rare Dis; 2016 Jul; 11(1):92. PubMed ID: 27387831
    [No Abstract]   [Full Text] [Related]  

  • 57. Skin Biopsy Findings in Patients With CMT1A: Baseline Data From the CLN-PXT3003-01 Study Provide New Insights Into the Pathophysiology of the Disorder.
    Duchesne M; Danigo A; Richard L; Vallat JM; Attarian S; Gonnaud PM; Lacour A; Péréon Y; Stojkovic T; Nave KA; Bertrand V; Nabirotchkin S; Cohen D; Demiot C; Magy L
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):274-281. PubMed ID: 29408953
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma.
    Zhou L; Zhan W; Wei X
    Front Pharmacol; 2022; 13():1015338. PubMed ID: 36313286
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Candidate imaging biomarkers for PMP22-related inherited neuropathies.
    Roth AR; Li J; Dortch RD
    Ann Clin Transl Neurol; 2022 Jul; 9(7):925-935. PubMed ID: 35656877
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.